We are pleased to share our latest white paper, A Successful Combination: The Ellele Device from Ellele Health and the HPV Profiler from Predica Diagnostics, the result of a scientific collaboration between Ellele Health and Predica Diagnostics.

This paper outlines a novel approach to cervical cancer screening, combining a speculum-free biospecimen collection device with a high-specificity molecular HPV test. Key highlights include:

• A user- and clinician-preferred alternative to conventional sampling

• High-quality samples suitable for DNA-based testing

• Promising potential to improve detection of high-risk HPV and CIN2+ lesions

Together, these innovations offer a pathway toward more accessible, patient-centric, and diagnostically robust cervical screening.

Predica Diagnostics BV is proud to join Tech4Eva - The global Femtech accelerator !

Predica was selected as one of the 16 companies out of 195 start-ups from 42 countries.

We look forward to engage with other companies in this great 2025 cohort: GICMED, LAYCO, MedSol AI Solutions, menoQueens, MoleSense, oasicare, Powerly, RephImmune Biotechnology, Salva Health, Silatha, Smartweave Inc, TIMSER GROUP, Woost, Xemperia, XENA.

Thanks to Simone Theiss and Lan Zuo Gillet for the great support !

Predica Diagnostics BV Diagnostics has been issued a European Union trade mark !